Anticarcinogenic effects of probiotics, prebiotics, and synbiotics

Handbook of Prebiotics and Probiotics Ingredients: Health Benefits and Food Applications

Volumn , Issue , 2009, Pages 273-292

  Jain, Shalini ^a   Yadav, Mukesh ^b   Menon, Saji ^c   Yadav, Hariom ^d   Marotta, Francesco ^e  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b JIWAJI UNIVERSITY   (India)

^c Birla Institute of Scientific Research   (India)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e Nutraceutical Nutragenomic Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NUTRITION;

ANTICARCINOGENIC EFFECT; BALANCED DIET; COMPLEX DISORDER; PREBIOTICS; PROBIOTICS;

DISEASES;

EID: 84863692927     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. Ballongue J, Schumann C, and Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol 1997; 222: 41-44.
2. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, and Sartor RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005; 100: 1539-46.
3. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995; 93: 55-71.
4. Bolognani F, Rumney CJ, and Rowland IR. Influence of carcinogen binding by lactic acid-producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens. Food Chem Toxicol 1997; 35: 535-45.
5. Campbell TC and Hayes JR. The effect of quantity and quality of dietary protein on drug metabolism. Fed Proc 1976; 35: 2470-74.
6. Choi SS, Kim Y, Han KS, You S, Oh S, and Kim SH. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett Appl Microbiol 2006; 42: 452-58.
7. Collins P, Mpofu C, Watson A, and Rhodes J. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006: CD000279.
8. Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, and Rowland IR. Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer 2005; 51: 102-9.
9. Duris I, Hruby D, Pekarkova B, Huorka M, Cernakova E, Bezayova T, and Ondrejika P. Calcium chemoprevention in colorectal cancer. Hepatogastroenterology 1996; 43: 152-54.
10. Eaton DL and Gallagher EP. Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 1994; 34: 135-72.
11. El-Nezami H, Kankaanpaa P, Salminen S, and Ahokas J. Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food Chem Toxicol 1998; 36: 321-26.
12. El-Nezami H, Kankaanpaa P, Salminen S, and Ahokas J. Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media. J Food Prot 1998; 61: 466-68.
13. Ferguson LR. Natural and man-made mutagens and carcinogens in the diet. Introduction to special issue of mutation research. Mutat Res 1999; 443: 1-10.
14. Ferguson LR, Zhu ST, and Harris PJ. Antioxidant and antigenotoxic effects of plant cell wall hydroxycinnamic acids in cultured HT-29 cells. Mol Nutr Food Res 2005; 49: 585-93.
15. Ghoneum M and Abedi S. Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). J Pharm Pharmacol 2004; 56: 1581-88.
16. Gibson G and Roberfroid M. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
17. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: A review. Am J Clin Nutr 2007; 86: 836S-842S.
18. Goldin BR and Gorbach SL. The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J Natl Cancer Inst 1976; 57: 371-75.
19. Goldin BR and Gorbach SL. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J Natl Cancer Inst 1980; 64: 263-65.
20. Goldin BR, Gualtieri LJ and Moore RP. The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. Nutr Cancer 1996; 25: 197-204.
21. Gorbach SL and Goldin BR. The intestinal microflora and the colon cancer connection. Rev Infect Dis 1990; 12: 252S-61S.
22. Grajek W, Olejnik A, and Sip A. Probiotics, prebiotics and antioxidants as functional foods. Acta Biochim Pol 2005; 52: 665-71.
23. Guengerich FP. Cytochromes P450, drugs, and diseases. Mol Interventions 2003; 3: 194-204.
24. Halliwell B. Oxidative stress and cancer: Have we moved forward? Biochem J 2007; 401: 1-11.
25. Hashimoto Y and Degawa M. Induction of cytochrome P450 isoforms by carcinogenic aromatic amines and carcinogenic susceptibility of rodent animals. Pharmacogenetics 1995; 5: S80-83.
26. Haskard C, Binnion C, and Ahokas J. Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG. Chem Biol Interact 2000; 128: 39-49.
27. Helsby NA, Zhu S, Pearson AE, Tingle MD, and Ferguson LR. Antimutagenic effects of wheat bran diet through modification of xenobiotic metabolising enzymes. Mutat Res 2000; 454: 77-88.
28. Henry SH, Bosch FX, Troxell TC, and Bolger PM. Policy forum: Public health. Reducing liver cancer-Global control of aflatoxin. Science 1999; 286: 2453-54.
29. Hirayama K and Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect 2000; 2: 681-86.
30. Johnson IT, Williamson G, and Musk SRR. Anticarcinogenic factors in plant foods: A new class of nutrients? Nutr Res Rev 1994; 7: 175-204.
31. Joseph P and Jaiswal AK. NAD(P)H: quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci U S A 1994; 91: 8413-17.
32. Kanazawa K, Konishi F, and Mitsuoka T. Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer 1996; 77: 1701-1706.
33. Kapila S. Studies on biodefensive properties of lactobacilli for their applications as probiotics. Ph.D. thesis, NDRI (Deemed University), Karnal, India, 2004.
34. Kapila S, Vibha, and Sinha PR. Antioxidative and hypocholesterolemic effect of Lactobacillus casei ssp casei (biodefensive properties of lactobacilli). Indian J Med Sci 2006; 60: 361-70.
35. Khalili K, Croul S, DelValle L, Krynska B, and Gordon J. Oncogenic potential of human neurotropic virus: Laboratory and clinical observations. Isr Med Assoc J 2001; 3: 210.
36. Kirlin WG, Cai J, DeLong MJ, Patten EJ, and Jones DP. Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells. J Nutr 1999; 129: 1827-35.
37. Kulkarni N and Reddy BS. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and faecal bacterial beta-glucuronidase. Proc Soc Exp Biol Med 1994; 207: 278-83.
38. Kullisaar T, Songisepp E, Mikelsaar M, Zilmer K, Vihalemm T, and Zimer M. Antioxidative probiotic fermented goat’s milk decreases oxidative stress mediated atherogenicity in human subjects. Br J Nutr 2003; 90: 449-56.
39. Lamprecht SA and Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: Molecular mechanisms. Nat Rev Cancer 2003; 3: 601-14.
40. Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Maurer-Jensen M, and Kadlubar FF. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 1994; 3: 675-82.
41. Langman M and Boyle P. Chemoprevention of colorectal cancer. Gut 1998; 43: 78-585.
42. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, Kim JY, Joo HG, and Woo HJ. Immunomodulatory and antitumor effects in-vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci 2004; 5: 41-48.
43. Lhoste EF, Nugon-Baudon L, Lory S, Meslin JC, and Andrieux C. The fermentation of lactulose in rats inoculated with Clostridium paraputrificum influences the activities of liver and intestinal xenobiotic-metabolising enzymes. J Sci Food Agric 2001; 81: 1397-1404.
44. Lin D, Meyer DJ, Ketterer B, Lang NP, and Kadlubar FF. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: A possible mechanism of organ specificity in their carcinogenesis. Cancer Res 1994; 54: 4920-26.
45. Lin MY and Chang FJ. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci 2000; 45: 1617-22.
46. Lin MY and Yen CL. Reactive oxygen species and lipid peroxidation product scavenging ability of yogurt organism. J Dairy Sci 1999; 82: 1629-34.
47. Maassen CB, van Holten-Neelen C, Balk F, den Bak-Glashouwer MJ, Leer RJ, Laman JD, Boersma WJ, and Claassen, E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 2000; 18: 2613-23.
48. Malkov S, Markelov VV, Barabanschikov BI, Marotta F, and Trushin MV. Oral administration of Bacillus oligonitrophilus KU-1 may prevent tumors. Asian Pac J Cancer Prev 2006 a; 7: 343.
49. Malkov SV, Markelov VV, Polozov GY, Barabanschikov BI, Kozhevnikov AY, and Trushin MV. Significant delay of lethal outcome in cancer patients due to per oral administration of Bacillus oligonitrophilus KU-1. Sci World J 2006 b; 6: 2177-87.
50. Markowitz S. TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. Biochim Biophys Acta 2000; 1470: M13-20.
51. Marotta F, Naito Y, Minelli E, Tajiri H, Bertuccelli J, Wu CC, Min CH, Hotten P, and Fesce E. Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: An experimental study. Hepatogastroenterology 2003; 50: 1914-18.
52. McIntosh GH, Royle PJ, and Playne MJ. A probiotic strain of L. acidophilus reduces DMHinduced large intestinal tumors in male Sprague-Dawley rats. Nutr Cancer 1999; 35: 153-59.
53. McLellan EA, and Bird RP. Aberrant crypts: Potential preneoplastic lesions in the murine colon. Cancer Res 1988; 48: 6187-92.
54. Moor WE and Holdeman LV. Discussion of the current bacteriological investigation of the relationship between intestinal flora, diet and colon cancer. Cancer Res 1975; 35: 3418-20.
55. Nugon-Baudon L, Roland N, Flinois JP, and Beaune P. Hepatic cytochrome P450 and UDPglucuronosyl transferase are affected by five sources of dietary fiber in germ-free rats. J Nutr 1996; 126: 403-409.
56. Okawa T, Niibe H, Arai T, Sekiba K, Noda K, Takeuchi S, Hashimoto S, and Ogawa N. Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. Cancer 1993; 72: 1949-54.
57. Orrhage, K., Sillerstrom, E., Gustafsson, J.-Å., Nord, C.E., and Rafter, J. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat. Research 1994; 311: 239-248.
58. Perdigon G, Alvarez S, Rachid M, Aguro G, and Gobbato N. Immune system stimulation by probiotics. J Dairy Sci 1995; 78: 1597-1606.
59. Pompei A, Cordisco L, Amaretti A, Zanoni S, Raimondi S, Matteuzzi D and Rossi M. Administration of folate-producing bifidobacteria enhances folate status in Wistar rats. J Nutr 2007; 137: 2742.
60. Pool-Zobel BL. Inulin-type fructans and reduction in colon cancer risk: Review of experimental and human data. Br J Nutr 2005; 93: S73-S90.
61. Pool-Zobel BL, Neudecker C, Domizlaff I, Ji S, Schillinger U, Rumney C, Moretti M, Vilarini I, Scassellati-Sforzoli R, and Rowland I. Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr Cancer 1996; 26: 365-80.
62. Potter JD. Colorectal cancer: Molecules and populations. J Natl Cancer Inst 1999; 91: 916-32.
63. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, Akira S, Takeda K, Lee J, Takabayashi K, and Raz E. Toll-like receptor 9 signaling mediates the antiinflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126: 520-28.
64. Rafter J. Probiotics and colon cancer. Best Pract Res Clin Gastroenterol 2003; 17: 849-59.
65. Rao CV, Sanders ME, Indrante C, Simi B, and Reddy BS. Prevention of colonic preneoplastic lesions by the probiotic Lactobacillus acidophilus NCFMTM in F34 rats. Int J Oncol 1999; 14: 939-44.
66. Reddy BS. The role of dietary fibers in colon cancer: An overview. Am J Med 1999; 106: 16S-19S.
67. Reddy BS, Hamid R, and Rao CV. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 1997; 18: 1371-74.
68. Roberfroid MB, Bornet F, Bouley C, and Cummings JH. Colonic microflora: Nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr Rev 1995; 53: 127-30.
69. Roller M, Pietro Femia A, Caderni G, Rechkemmer G, and Watzl B. Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br J Nutr 2004; 92: 931-38.
70. Rowland IR, Rumney CJ, Coutts JT, and Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998; 19: 281-85.
71. Saikali J, Picard C, Freitas M, and Holt PR. Fermented milks, probiotic cultures, and colon cancer. Nutr Cancer 2004; 49: 14-24.
72. Salim EI, Morimura K, Menesi A, El-Lity M, Fukushima S, and Wanibuchi H. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int J Cancer 2008; 123: 601-608.
73. Sanders JW, Leehout KJ, Haanbrikmam AJ, Venema G, and Kok J. Stress response in Lactococcus lactis: Cloning, expression analysis and mutation of the lactococcal super oxide dismutase gene. J Bacteriol 1995; 177: 5254-60.
74. Sarkali J, Picard C, Freitas M, and Holt P. Fermented milks, probiotic cultures, and colon cancer. Nutr Cancer 2004; 49: 14-24.
75. Sekine K, Ohta J, Onishi M, Tatsuki T, Shimokawa Y, Toida T, Kawashima T, and Hashimoto Y. Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. Biol Pharm Bull 1995; 18: 148-53.
76. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, and Reddy BS. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 1997; 18: 833-41.
77. Smalley W, Ray WA, Daugherty J, and Griffin MR. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer. Arch Intern Med 1999; 159: 161-66.
78. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, and Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289: 1352-55.
79. Sun J, Shi YH, Le GW, and Ma XY. Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. World J Gastroenterol 2005; 11: 6330-37.
80. Terahara M, Nishide S, and Kaneko T. Preventive effect of Lactobacillus delbrueckii subsp. bulgaricus on the oxidation of LDL. Biosci Biotechnol Biochem 2000; 64: 1868-73.
81. Thyagaraja N and Hosono A. Antimutagenicity of lactic acid bacteria from “Idly” against food-related mutagens. J Food Protection 1993; 56: 1061-66.
82. Toft NJ and Arends MJ. DNA mismatch repair and colorectal cancer. J Pathol 1999; 185: 123-29.
83. Tooley K, Howarth G, Lymn K, Lawrence A, and Butler R. Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol Ther 2006; 5: 593-600.
84. Usman-Hosono A. Desmutagenicity of milk cultured with Lactobacillus acidophilus strains against mutagenic heated tauco. Food Chem Toxicol 1998; 36: 805-10.
85. Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Stenling R, Riboli E, Winkvist A, and Palmqvist R. Low folate levels may protect against colorectal cancer. Gut 2006; 55: 1461-66.
86. Vibha. Effect of standard lactobacilli on cardiovascular disease risk factors for their potential application as probiotics. Ph.D. thesis, NDRI (Deemed University), Karnal, India, 2004.
87. Wollowski I, Ji ST, Bakalinsky AT, Neudecker C and Pool-Zabel BL. Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J Nutr 1999; 129: 77-82.
88. Wollowski I, Rechkemmer G and Pool-Zobel BL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 2001; 73: 451S-455S.
89. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 1997.
90. Yadav H, Jain S, Sinha PR, and Marrota F. Diabetes and probiotics: A possible therapeutic link. Int J Probiotics Prebiotics 2007; 2: 15-20.
91. Yadav H, Jain S, and Sinha PR. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei ameliorated the Streptozotocin-induced oxidative stress and dyslipidemia in rats. J Dairy Res 2008; 75: 189-95.
92. Yamazaki K, Tsunoda A, Sibusawa M, Tsunoda Y, Kusano M, Fukuchi K, Yamanaka M, Kushima M, Nomoto K, and Morotomi M. The effect of an oral administration of Lactobacillus casei strain Shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol Rep 2000; 7: 977-82.
93. Younes H, Coudray C, Bellanger J, and Demigne C, et al., Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats. Br J Nutr 2001; 86: 479-85.
94. Zommara M, Takagi H, Sakono M, Suzuki Y, and Imaizumi K. Effect of milk whey and its fermentation products by lactic acid bacteria on mitochondrial lipid peroxide and hepatic injury in bile duct-ligated rats. Biosci Biotech Biochem 1994; 58: 1213-17.
95. Zommara M, Tachibana N, Sakono M, Suzuki Y, Hashiba H, and Imaizami K. Whey from cultured skim milk decreases serum cholesterol and increases antioxidant enzymes in liver and red blood cells in rats. Nutr Res 1996; 16: 293-302.
96. Zommara M, Toubo H, Sakono M, and Imaizumi K. Prevention of peroxidative stress in rats fed on a low vitamin E containing diet by supplementing with a fermented bovine milk whey preparation: Effect of lactic acid and β-lactoglobulin on the antiperoxidative action. Biosci Biotechnol Biochem 1998; 62: 710-17.